VEGFA and wet macular degeneration: Loss of visual acuity is used as the main outcome in many clinical studies [31] including a UK national database study of treatment-naïve eyes with wet AMD treated with a an anti-vascular endothelial growth factor antibody with follow-up over three years [32].